Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry

CD44 has been known as a marker of tumor-initiating cells, and plays pro-tumorigenic functions in many cancers. The splicing variants play critical roles in the malignant progression of cancers by promoting stemness, cancer cell invasion or metastasis, and resistance to chemo- and radiotherapy. To u...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Tanaka, Tomohiro, Goto, Nohara, Kaneko, Mika K., Kato, Yukinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047040/
https://www.ncbi.nlm.nih.gov/pubmed/36975491
http://dx.doi.org/10.3390/cimb45030121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047040/
https://www.ncbi.nlm.nih.gov/pubmed/36975491
http://dx.doi.org/10.3390/cimb45030121

Ejemplares similares